While restrictive transfusion hemoglobin (Hb) thresholds are appropriate for most patients, those with anemia and myocardial infarction (MI) may benefit from the improved oxygen delivery to the heart and other tissues provided by more liberal hemoglobin thresholds. In the 2023 MINT (Myocardial Ischemia and Transfusion) trial, a restrictive transfusion strategy (Hb < 7 to 8 g/dL) conferred a 15% greater…
Prevalence and Trends of Maternal RBC Alloimmunization in the U.S.
Tranexamic Acid Does Not Reduce Bleeding or Transfusions in Patients Undergoing Liver Resection
Blood Donation Rates Higher in Countries with Higher Healthcare Quality and Expenditure
Nipocalimab Delays Intrauterine Transfusions for Severe Hemolytic Disease of the Fetus and Newborn
Updated FDA Guidance for Blood Donor Eligibility for Blood Pressure and Pulse
Carnitine Metabolism Associated with Red Blood Cell Hemolysis
No Transfusion-Transmission of Classic Creutzfeldt-Jakob Disease
Copyright © 2024 John Wiley & Sons, Inc. All Rights Reserved.
Privacy Policy